A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.

Also called NCT06370715

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 153 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06370715
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06370715. Allocation not applicable; no masking; primary purpose treatment. Start 2024-04-18 (actual); primary completion 2025-09-02 (actual). Results posted on 2026-09-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Insulin Lispro-aabc
Intervention (Drug)
Insulin Glargine
Lead sponsor
Eli Lilly and Company (class: industry)
Collaborator
Cipla Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06370715
Content hash
975bd976b14d4c0da1266022bdff4aaa9106466025b8c7b724677bf995a36a21